Drug profile · INN
chlorothiazide sodium
CHLOROTHIAZIDE SODIUM
chlorothiazide sodium (CHLOROTHIAZIDE SODIUM) is a thiazide-sensitive sodium-chloride cotransporter inhibitor. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.
Drug details — chlorothiazide sodium
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
chlorothiazide sodium (CHLOROTHIAZIDE SODIUM) is a thiazide-sensitive sodium-chloride cotransporter inhibitor. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Thiazide-sensitive sodium-chloride cotransporter inhibitor
Primary target: Solute carrier family 12 member 3
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is chlorothiazide sodium?
chlorothiazide sodium (CHLOROTHIAZIDE SODIUM) is a thiazide-sensitive sodium-chloride cotransporter inhibitor. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.
What is the brand name for chlorothiazide sodium?
CHLOROTHIAZIDE SODIUM is a marketed brand name for chlorothiazide sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of chlorothiazide sodium?
chlorothiazide sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.